EnPlusOne Biosciences

$21.8Mlatest round · Venture round · Aug 2022 · 4 yr ago
1backers · Coatue
50+team · employees, estimated range
2022founded

Overview

We make better RNA. Solving today’s limitations. Unlocking tomorrow’s innovations. Urgent need RNA therapeutics are accelerating faster than current manufacturing technologies can support. Untapped potential Nature encodes >200 RNA modifications – chemical synthesis only accesses ~20.

Funding and backers

Total raised
$21.8M
1 round on record
Latest round
$21.8M
Venture round · Aug 2022 · 4 yr ago
Team
51-200
employees, estimated range
Backers
1
Coatue
The money's age
Long since its last round
50 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 30, 2022 Raised a round Venture round $21.8M · SEC Form D 2022 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Aug 2022 $21.8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity EnPlusOne Biosciences Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Daniel AhlstedtExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Coatue fund
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs Rise Reforming
Greylock
backs Atomic
High-Tech Gründerfonds
backs Umlaut
Global Brain
backs Rhelixa
ARCH Venture Partners
backs Singular Genomics Systems
Playground
backs Atomic
Similar startupsby what they do, their industry and backers
AlidaBioVenture round $7.5M · 2 yr ago · Founded 2020
EpiPlex™ assay detects RNA modifications by proximity barcoding and short read RNA sequencing, revealing insights into gene regulation for…
La Jolla LabsConvertible Note $3.5M · 5 yr ago · Founded 2020 · 11-50 employees
Experts in Design and Discovery for RNA Therapeutics | Design custom RNA therapeutics and propel your programs towards the clinic. Let La…
Rootline
Embedded payments for modern commerce. Your current financial infrastructure wasn't built for your platform. Rootline is.
Rise Reforming51-200 employees
Unlocking resiliencefor the chemical industry.
Rhelixa
ゲノム （ DNA ）、エピゲノム、トランスクリプトーム （ RNA ）を独自の技術で解析し、研究開発の効率・精度を格段に向上させます。次世代シーケンス（ NGS ）／ エピジェネティクス 研究の 実験デザイン から 情報 解析、論文化、事業化までオーダーメイドで支援します。.
Umlaut51-200 employees
Decoding RNA modifications to revolutionize cancer and inflammation treatment. Umlaut.bio GmbH is a pioneering biotech company focused on…

Financials

Total raised
$21.8M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2022 $21.8M Details

People

Daniel Ahlstedt
Executive Officer, Director
SEC Form D
Paxton Major
Director
SEC Form D
Andrew Lee
Director
SEC Form D
Steven Kasok
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
CoatueVia a fund
344 portfolio companies: Kalshi, Zuoyebang, Instinct and 341 more
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Watertown United States
HQ
Let’s get connected
50-200 est. staff
HQ 313 Pleasant Street Suite 4W Watertown, MA 02472
company site